ImpediMed (ASX:IPD): Why Has This Healthcare Stock Suddenly Grabbed Attention?
Highlights A significant insider share purchase has placed ImpediMed back on the radar of market participants. The medical technology company continues to expand the commercial reach of its bioimpedance spectroscopy platform. Strong insider ownership activity has intensified focus on the company's long-term healthcare growth strategy. ImpediMed is drawing renewed attention following major insider buying activity, healthcare technology innovation and expanding opportunities in patient monitori...

